Kanagawa, Japan

Takeshi Kaneda



 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Takeshi Kaneda

Introduction

Takeshi Kaneda is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of methods for producing optically active compounds. With a total of 2 patents to his name, Kaneda's work is recognized for its impact on pharmaceutical research.

Latest Patents

Kaneda's latest patents include a preparation method for optically active diamine compounds. This invention addresses the need for an efficient production method for important intermediate compounds used in the creation of FXa inhibitors. The solution involves a stereoselective intramolecular cyclization reaction, which allows for the production of specific compounds. Additionally, he has developed optical resolution methods for bicyclic compounds using asymmetric catalysts, enabling the efficient production of optically active bicyclic compounds through the use of optically active amines.

Career Highlights

Takeshi Kaneda is currently associated with Daiichi Sankyo Company, Limited, where he continues to innovate in the field of pharmaceutical chemistry. His work has contributed to advancements in drug development and has positioned him as a key figure in his area of expertise.

Collaborations

Throughout his career, Kaneda has collaborated with esteemed colleagues such as Yoshitaka Nakamura and Takafumi Kitawaki. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.

Conclusion

Takeshi Kaneda's contributions to the field of chemistry through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the pharmaceutical industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…